These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28930535)

  • 41. Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription.
    Liao CL; Lai MM
    J Virol; 1994 Aug; 68(8):4727-37. PubMed ID: 8035475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro.
    van Hemert MJ; van den Worm SH; Knoops K; Mommaas AM; Gorbalenya AE; Snijder EJ
    PLoS Pathog; 2008 May; 4(5):e1000054. PubMed ID: 18451981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of SARS-CoV replication by siRNA.
    Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL
    Antiviral Res; 2005 Jan; 65(1):45-8. PubMed ID: 15652970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis.
    Ren W; Li W; Yu M; Hao P; Zhang Y; Zhou P; Zhang S; Zhao G; Zhong Y; Wang S; Wang LF; Shi Z
    J Gen Virol; 2006 Nov; 87(Pt 11):3355-3359. PubMed ID: 17030870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins.
    Prentice E; McAuliffe J; Lu X; Subbarao K; Denison MR
    J Virol; 2004 Sep; 78(18):9977-86. PubMed ID: 15331731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [SARS coronavirus].
    Taguchi F
    Uirusu; 2003 Dec; 53(2):201-9. PubMed ID: 15071959
    [No Abstract]   [Full Text] [Related]  

  • 47. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
    Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
    Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of severe acute respiratory syndrome coronavirus membrane protein.
    Voss D; Kern A; Traggiai E; Eickmann M; Stadler K; Lanzavecchia A; Becker S
    FEBS Lett; 2006 Feb; 580(3):968-73. PubMed ID: 16442106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
    Wang X; Zhao Y; Yan F; Wang T; Sun W; Feng N; Wang W; Wang H; He H; Yang S; Xia X; Gao Y
    J Virol; 2021 Aug; 95(18):e0060021. PubMed ID: 34106002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for coronavirus discontinuous transcription.
    Jeong YS; Makino S
    J Virol; 1994 Apr; 68(4):2615-23. PubMed ID: 8139040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promoter activity of SARS coronavirus 5' UTR sequence in eukaryotic cells.
    Zhang JJ; Huang AL; Shi XL; Zhang XF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):5-9. PubMed ID: 16468630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference.
    Zhang Y; Li T; Fu L; Yu C; Li Y; Xu X; Wang Y; Ning H; Zhang S; Chen W; Babiuk LA; Chang Z
    FEBS Lett; 2004 Feb; 560(1-3):141-6. PubMed ID: 14988013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.
    Yount B; Curtis KM; Fritz EA; Hensley LE; Jahrling PB; Prentice E; Denison MR; Geisbert TW; Baric RS
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12995-3000. PubMed ID: 14569023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS coronavirus and apoptosis.
    Chow KY; Yeung YS; Hon CC; Zeng F; Law KM; Leung FC
    Hong Kong Med J; 2008 Aug; 14 Suppl 4():8-13. PubMed ID: 18708667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites.
    Wang Y; Cao YL; Yang F; Zhang Y; Wang SH; Liu L
    Molecules; 2010 Oct; 15(10):7197-207. PubMed ID: 20956884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
    Drosten C; Günther S; Preiser W; van der Werf S; Brodt HR; Becker S; Rabenau H; Panning M; Kolesnikova L; Fouchier RA; Berger A; Burguière AM; Cinatl J; Eickmann M; Escriou N; Grywna K; Kramme S; Manuguerra JC; Müller S; Rickerts V; Stürmer M; Vieth S; Klenk HD; Osterhaus AD; Schmitz H; Doerr HW
    N Engl J Med; 2003 May; 348(20):1967-76. PubMed ID: 12690091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.
    Giroglou T; Cinatl J; Rabenau H; Drosten C; Schwalbe H; Doerr HW; von Laer D
    J Virol; 2004 Sep; 78(17):9007-15. PubMed ID: 15308697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased viral titers and subtle changes in plaque morphology upon passage of SARS-CoV in cells from different species.
    Gillim-Ross L; Heller LK; Olivieri ER; Wentworth DE
    Adv Exp Med Biol; 2006; 581():259-63. PubMed ID: 17037539
    [No Abstract]   [Full Text] [Related]  

  • 59. Leader-mRNA junction sequences are unique for each subgenomic mRNA species in the bovine coronavirus and remain so throughout persistent infection.
    Hofmann MA; Chang RY; Ku S; Brian DA
    Virology; 1993 Sep; 196(1):163-71. PubMed ID: 8356793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic sequencing of the severe acute respiratory syndrome-coronavirus.
    Chim SS; Chiu RW; Lo YM
    Methods Mol Biol; 2006; 336():177-94. PubMed ID: 16916263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.